Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Biogen Idec, Elan Start First Cancer Trial With Tysabri
|
Luke Timmerman |
09/05/08 |
|
Boston
|
|
Pathway Medical, With FDA Clearance in Hand, Starts Selling Device for Wiping Out Blockages in Leg Arteries
|
Luke Timmerman |
09/05/08 |
|
Seattle
|
|
Alnylam Sees Opportunity in Turning Genes On, And Off
|
Luke Timmerman |
09/05/08 |
|
Boston
|
|
Gates Foundation Calls for Proposals to Solve Global Health “Grand Challenges”
|
Luke Timmerman |
09/04/08 |
|
Seattle
|
|
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease
|
Luke Timmerman |
09/04/08 |
|
Seattle
|
|
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA
|
Luke Timmerman |
09/03/08 |
|
Seattle
|
|
Oncothyreon To Sell Stock, Bet Resources on Developing Two Cancer Drugs
|
Luke Timmerman |
09/02/08 |
|
Seattle
|
|
Targanta Antibiotic Shown Effective in Less-Frequent Dose
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
Hepregen Raises $3 Million To Screen Drugs for Liver Damage
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval
|
Luke Timmerman |
09/02/08 |
|
Seattle
|
|
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
Investors Radio in $32M for Vanu, JumpTap’s Bank Balance Hops up by $26M, Quanterix Pinpoints $15M, & More Deals News
|
Rebecca Zacks |
09/02/08 |
|
Boston
|
|
Ikaria Developing Drug For “Hibernation-on-Demand,” Could Pull Off Biggest Biotech IPO Ever, VC Says
|
Luke Timmerman |
09/02/08 |
|
Seattle
|
|
Ariad Pharmaceuticals Edging Toward Becoming a Commercial Cancer Drug Company
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
Boston Scientific Gets Damages Reduced in Patent Case with Medtronic
|
Luke Timmerman |
08/29/08 |
|
Boston
|
|
ZymoGenetics Sells Land for $11.5 Million
|
Luke Timmerman |
08/29/08 |
|
Seattle
|
|
Impel NeuroPharma Develops Novel Delivery System to Get Drugs Into the Brain
|
Luke Timmerman |
08/29/08 |
|
Seattle
|
|
Quanterix Developing Instrument to Detect Cancer at its Earliest, Most Curable Stages
|
Luke Timmerman |
08/29/08 |
|
Boston
|
|
SonoSite Marketing Boss Resigns to Take Job at Smith & Nephew
|
Luke Timmerman |
08/28/08 |
|
Seattle
|
|
Dendreon Rival Suffers Meltdown, Investors Sitting Tight For Next Big Clinical Trial News
|
Luke Timmerman |
08/28/08 |
|
Seattle
|
|
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections
|
Luke Timmerman |
08/28/08 |
|
Seattle
|
|
Ultrasound Stethoscopes, Stealthy Software, A New Enzyme Startup, and More from Alexandria Real Estate’s Summer Celebration
|
Gregory T. Huang |
08/28/08 |
|
Seattle
|
|
Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis
|
Luke Timmerman |
08/27/08 |
|
Boston
|
|
UW TechTransfer’s Linden Rhoads Aiming to Nurture More Startups, Entice More VCs to Look at UW’s Research Cupboard
|
Luke Timmerman |
08/27/08 |
|
Seattle
|
|
Amazon Acquires Shelfari; SnapIn Gets Snapped Up by Nuance; AltaRock Closes Funding Round with Vulcan, Google, and ATV; & More
|
Gregory T. Huang |
08/27/08 |
|
Seattle
|
|
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
|
Rebecca Zacks |
08/27/08 |
|
Boston
|
|
QLT Licenses Atrigel Rights to Reckitt Benckiser
|
Luke Timmerman |
08/26/08 |
|
Seattle
|
|
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling
|
Luke Timmerman |
08/26/08 |
|
Boston
|
|
Polaris and MIT’s Langer Meet L’Oreal. Don’t Believe It? There’s “Living Proof”
|
Ryan McBride |
08/26/08 |
|
Boston
|
|
With Intellectual Ventures, Nathan Myhrvold Out to Create “Invention Capital” Industry—and Stop Hurricanes, Malaria, and Global Warming in the Process (Part 2)
|
Gregory T. Huang |
08/26/08 |
|
Seattle
|
|
Page 1 of
18 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
